Boston March 4-7, 2018 Program and Conference Information
Total Page：16
File Type：pdf, Size：1020Kb
Program and Conference Information Conference on Retroviruses and Opportunistic Infections Boston March 4-7, 2018 General Information CONTENTS Information General CROI FOUNDATION ...........................................................2 IAS–USA.......................................................................2 CROI 2018 PROGRAM COMMITTEE.........................................3 Scientific Program Committee .........................................3 Community Liaison Subcommittee .....................................5 EXTERNAL REVIEWERS . 6 SCHOLARSHIP AWARDEES ..................................................8 New Investigator Awardees.................................................8 International Investigator Awardees .......................................12 Community Educator Awardees............................................12 CONTINUING MEDICAL EDUCATION ......................................13 GENERAL INFORMATION . .15 Overview .................................................................15 Conference Support .......................................................15 Americans With Disabilities Act ............................................15 Emergency Services . .15 Embargo Policies and Social Media ....................................16 Welcome Reception .......................................................16 Meals.....................................................................16 Overflow Accommodations for Oral Sessions................................17 Mobile App ...............................................................17 Website...................................................................17 Webcasts .................................................................17 Affiliated and Proximate Activities Policy ...................................18 Wi-Fi Access at the Conference .............................................18 Conference Badges ........................................................18 Child Care.................................................................18 Conference Etiquette ......................................................18 CROI HOTELS.................................................................19 CONFERENCE SERVICES ....................................................22 ABSTRACT PROCESS ........................................................24 PRECONFERENCE AND ORAL SESSIONS . .26 POSTER SESSIONS, BY DAY.................................................64 POSTER SESSIONS, BY CATEGORY........................................168 INDEX OF STUDIES RELATED TO WOMEN................................172 INDEX OF PRESENTING AUTHORS .......................................179 CONFERENCE SCHEDULE ..................................INSIDE BACK COVER CONVENTION CENTER FLOOR PLANS ...........................BACK COVER Printed in the United States of America. © Copyright 2018 CROI Foundation/IAS–USA. All rights reserved. ISBN #978-1-7320053-0-3 CROI 2018 1 General Information CROI FOUNDATION The CROI Foundation is a 501(c)(3) not-for-profit professional organization that operates exclusively for the charitable and educational purpose of organizing, promoting, and presenting the annual Conference on Retroviruses and Opportunistic Infections (CROI). General Information Information General Roles and Responsibilities of the CROI Foundation Volunteer Board of Directors • Works closely with the CROI Scientific Program Committee (CROI PC) and the CROI Secretariat to accomplish the mission of CROI • Approves nominations for members of the CROI PC and the CROI PC Chair and Vice Chairs • Ensures that the CROI PC is responsible for the scientific program content of CROI • Enters into and oversees the partner agreement with the CROI Secretariat • Has the sole and absolute discretion to veto any policies, procedures, or actions taken or proposed to be taken by the CROI PC or the CROI Secretariat that would pose a substantial risk of preventing the Foundation at any time from qualifying or continuing to qualify as a 501(c)(3) organization or that might cause the loss of such qualification • Oversees the long-term financial and administrative integrity of CROI CROI Foundation Board of Directors Constance A. Benson, MD Kevin M. De Cock, MD President Centers for Disease Control and Prevention University of California San Diego Nairobi, Kenya San Diego, CA, United States Scott M. Hammer, MD John M. Coffin, PhD Columbia University Secretary-Treasurer New York, NY, United States Tufts University Boston, MA, United States Sharon L. Hillier, PhD University of Pittsburgh Elaine J. Abrams, MD Pittsburgh, PA, United States ICAP at Columbia University New York, NY, United States John W. Mellors, MD University of Pittsburgh Susan P. Buchbinder, MD Pittsburgh, PA, United States San Francisco Department of Public Health Robert T. Schooley, MD San Francisco, CA, United States University of California San Diego La Jolla, CA, United States Judith S. Currier, MD, MSc University of California Los Angeles Los Angeles, CA, United States IAS–USA The International Antiviral Society–USA is a 501(c)(3) not-for-profit professional education organization. The IAS–USA partners with the CROI PC and Foundation to organize CROI. The mission of the IAS–USA is to improve the prevention, treatment, care, and quality of life for people with or at risk of HIV, hepatitis C virus, or other viral infections through high-quality, relevant, balanced, and needs-oriented education and information for practitioners and scientists who are actively involved in medical care and research. Executive Director: Donna M. Jacobsen Address: 425 California Street, Suite 1450 San Francisco, CA 94104-2120 Phone: 415-544-9400 Website: www.iasusa.org 2 CROI 2018 General Information CROI 2018 PROGRAM Information General COMMITTEE The Scientific Program Committee (PC) is a team of experts in their given field who volunteer to organize the scientific program for CROI. Members are selected based on their area of scientific expertise and their commitment to the mission of the conference. Initial terms are up to 3 years; subsequent terms are based on previous participation and interest level. Members are nominated by the PC and approved by the CROI Foundation Board of Directors. The PC members are responsible for identifying topics and speakers that will ensure innovative programming; strategic planning; abstract review and program development; and organizing, conducting, or convening workshops, symposia, and special sessions. Scientific Program Committee Judith S. Currier, MD, MSc CROI 2018 Chair University of California Los Angeles Los Angeles, CA United States Sharon L. Hillier, PhD Richard A. Koup, MD CROI 2018 Vice Chair CROI 2018 Vice Chair University of Pittsburgh Vaccine Research Center Pittsburgh, PA National Institute of Allergy United States and Infectious Diseases National Institutes of Health Bethesda, MD, United States Elaine J. Abrams, MD Susan P. Buchbinder, MD ICAP at Columbia University San Francisco Department of New York, NY, United States Public Health San Francisco, CA, USA Adaora Adimora, MD Connie L. Celum, MD, MPH University of North Carolina University of Washington at Chapel Hill Seattle, WA, United States Chapel Hill, NC, United States Galit Alter, PhD Richard E. Chaisson, MD Ragon Institute of MGH, MIT The Johns Hopkins University and Harvard Baltimore, MD, United States Cambridge, MA United States Constance A. Benson, MD Nicolas Chomont, PhD University of California Université de Montréal San Diego Montreal, Canada San Diego, CA, United States Paul Bieniasz, PhD John M. Coffin, PhD The Rockefeller University Tufts University New York, NY, United States Boston, MA, United States CROI 2018 3 General Information Kevin M. De Cock, MD Ilesh V. Jani, MD, PhD Centers for Disease Control Instituto Nacional de Saude and Prevention Maputo, Mozambique Nairobi, Kenya Wafaa M. El-Sadr, MD, MPH Frank Kirchhoff, PhD ICAP at Columbia University Ulm University General Information Information General New York, NY, United States Medical Center Ulm, Germany Joseph J. Eron, Jr, MD Dennis L. Kolson, MD, PhD University of North Carolina University of Pennsylvania at Chapel Hill Philadelphia, PA Chapel Hill, NC, United States United States Courtney V. Fletcher, Hermione Lyall, MD PharmD Imperial College Healthcare University of Nebraska National Health Medical Center Service Trust Omaha, NE, United States London, United Kingdom Huldrych F. Günthard, MD James A. McIntyre, University Hospital Zurich MBChB, FRCOG Zurich, Switzerland Anova Health Institute Johannesburg, South Africa Timothy Hallett, PhD John W. Mellors, MD Imperial College London University of Pittsburgh London, United Kingdom Pittsburgh, PA, United States Scott M. Hammer, MD Nelly R. Mugo, MBChB, Columbia University MPH New York, NY, United States Kenya Medical Research Institute Nairobi, Kenya Diane V. Havlir, MD Landon Myer, MD, PhD University of California University of Cape Town San Francisco Cape Town, South Africa San Francisco, CA United States James A. Hoxie, MD Andrew N. Phillips, PhD University of Pennsylvania University College London Philadelphia, PA London, United Kingdom United States Peter W. Hunt, MD Peter Reiss, MD, PhD University of California Amsterdam Institute San Francisco for Global Health San Francisco, CA and Development United States Amsterdam, Netherlands 4 CROI 2018 General Information Douglas D. Richman, MD Serena S. Spudich, MD, MA Information General University of California Yale University San Diego; Veterans Affairs New Haven, CT, United